Medication Fact Sheets
|
November 26, 2024

Erythromycin Eye Ointment: Benefits, Application & Safety

Written By
Medically Reviewed by
Updated On
December 2, 2024

Erythromycin ophthalmic ointment is a widely used antibiotic for treating certain eye infections. It is a soft, topical form designed to target bacteria directly in the eye. Doctors and eye specialists commonly prescribe this medication for conditions like bacterial conjunctivitis and to prevent infections in newborns.

This article explains the benefits of erythromycin eye ointment, how to apply it safely, and what to keep in mind while using it. The goal is to provide clear, practical information for healthcare professionals and patients.

[signup]

What is Erythromycin Ophthalmic Ointment?

Erythromycin ophthalmic ointment is an antibiotic medication specifically formulated for the eyes. The active ingredient is erythromycin, a macrolide antibiotic known for its ability to stop the growth of bacteria by interfering with their protein synthesis.

The ointment is a sterile, smooth preparation, often blended with a base like mineral oil or petrolatum. These inactive ingredients help the medication spread evenly over the eye's surface and stay in place for prolonged contact.

How Erythromycin Works

Erythromycin targets bacterial infections by preventing the bacteria from making essential proteins needed for their survival and growth.Β 

This action doesn't kill the bacteria outright but inhibits their ability to reproduce, allowing the immune system to clear the infection more effectively.Β 

It is especially effective against Gram-positive bacteria and some Gram-negative bacteria, making it useful for specific eye infections.

Conditions Treated

Erythromycin eye ointment is commonly prescribed for:

Comparison with Other Ophthalmic Antibiotics

Erythromycin is one of several options for treating bacterial eye infections. Here's how it compares:

  • Polymyxin B combinations (e.g., Polymyxin B + Trimethoprim): These are effective against a broader range of Gram-negative bacteria but may require more frequent application than erythromycin.
  • Tobramycin: Another commonly used antibiotic, tobramycin, is effective against Gram-negative bacteria and is often chosen for more severe infections. However, it may cause more irritation in sensitive eyes.
  • Ciprofloxacin and other fluoroquinolones: These are used for more resistant infections but may not be necessary for milder cases where erythromycin is sufficient.

How to Apply Erythromycin Ophthalmic Ointment

Using erythromycin eye ointment correctly ensures it works effectively and minimizes the risk of complications. Follow these simple steps:

  1. Use soap and water to thoroughly wash your hands before touching your eyes or the ointment tube.
  2. Remove the cap from the ointment tube, and do not touch the tip to avoid contamination.
  3. Tilt your head back. Sit or lie down in a comfortable position and look upward.
  4. Gently pull down the lower eyelid.
  5. Squeeze a thin strip (about 1 cm or as directed by your healthcare provider) of ointment into the pocket without letting the tube tip touch your eye, fingers, or skin.
  6. After application, gently close your eyes for 1–2 minutes to allow the ointment to spread evenly over the surface of the eye. Avoid blinking excessively.
  7. Use a clean tissue to gently dab away excess ointment from around the eye if necessary.

Dosage Frequency

Follow your doctor's instructions for how often to apply the ointment. Depending on the severity of the infection, the ointment is commonly applied up to six times daily. For newborns, a single application may suffice for infection prevention.

Best Practices and Precautions

  • Always wash your hands after applying the ointment to prevent spreading bacteria.
  • To avoid contaminating the tube, never touch the tip of the tube to your eye, fingers, or any other surface. Keep the cap on when not in use.
  • Do not share the ointment, as sharing could spread infection or contamination.

Tips for Reducing Side Effects

  • Blurred Vision: Temporary blurred vision is a common side effect after applying ointment. To avoid accidents, wait until your vision clears before driving or performing tasks that require sharp vision.
  • Avoid Wearing Contact Lenses: Contacts can trap bacteria and reduce the ointment's effectiveness. Use glasses during treatment unless your doctor advises otherwise.
  • Report Persistent Symptoms: If irritation, redness, or symptoms worsen after a few days of use, contact your doctor promptly.

Efficacy and Benefits of Erythromycin Ophthalmic Ointment

Erythromycin is a macrolide antibiotic that targets bacteria responsible for eye infections. It blocks the bacteria's ability to produce essential proteins needed for growth and reproduction, inhibiting bacterial replication and allowing the immune system to clear the infection more effectively.

Unlike antibiotics that destroy bacterial cell walls (like penicillins), erythromycin is gentler on tissues, making it ideal for delicate areas like the eyes. It's particularly effective against Gram-positive bacteria and certain Gram-negative bacteria that commonly cause eye infections.

Benefits of Using Erythromycin for Eye Care

Erythromycin ophthalmic ointment offers several advantages for treating bacterial eye infections and preventing complications. Below are its key benefits:

Gentle and Safe for Sensitive Eyes

Erythromycin is formulated to minimize irritation, making it suitable for patients with sensitive eyes or those prone to allergic reactions. Its petrolatum-based ointment also provides a soothing barrier, which may help protect the eye while fighting the infection.

Suitable for Allergies to Other Medications

Patients allergic to penicillin or sulfa-based drugs can often use erythromycin safely, as it belongs to a different antibiotic family.

Effective in Pediatric Care

Erythromycin is a trusted option for children and newborns. It is frequently used to prevent ophthalmia neonatorum, a potentially serious eye infection in newborns caused by bacteria. Its mild formulation ensures safety while protecting delicate newborn eyes.

Preventive and Therapeutic Uses

Erythromycin can be used to treat active bacterial infections and as a prophylactic measure to prevent them, such as minor eye injuries or surgeries.

Potential Side Effects and Risks

While erythromycin ophthalmic ointment is generally well-tolerated, some individuals may experience minor side effects, including:

  • Temporary blurred vision
  • Mild irritation or redness
  • Stinging or burning sensation

These side effects are typically short-lived and do not require medical attention unless they persist or worsen.

Allergic Reactions and Serious Risks

Although rare, erythromycin can cause allergic reactions or more severe issues in some patients. Watch for these symptoms, which may require immediate medical attention:

  • Severe swelling or redness, mainly if it spreads beyond the eye area.
  • Intense itching or rash.
  • Difficulty breathing or swelling of the face/lips may indicate a severe allergic response called anaphylaxis.
  • Persistent pain or discomfort.

Minimizing Risks

Use only the amount and frequency recommended by your healthcare provider to reduce the likelihood of side effects or complications. Overuse can increase irritation and lead to resistance.

Do not let the ointment tube tip touch your eye, fingers, or other surfaces. If irritation or symptoms become more severe after starting treatment, consult a doctor promptly.

Erythromycin and Antibiotic Resistance

Antibiotic resistance occurs when bacteria evolve and become less responsive to medications designed to kill them. This can make infections more challenging to treat and lead to more severe or prolonged illnesses.Β 

Misuse or overuse of antibiotics, including topical forms like erythromycin, is a significant contributor to this problem.

With ophthalmic ointments, resistance can develop if:

  • Patients stop using the medication too soon.
  • Antibiotics are used when they're not needed, such as for viral eye infections.
  • The medication is applied incorrectly or excessively.

Preventative Measures for Patients

To help prevent resistance:

  • Complete the Prescribed Course: Even if symptoms improve, finish the entire treatment duration unless your doctor advises otherwise.
  • Use Only When Necessary: Avoid using erythromycin ointment for non-bacterial eye issues, such as viral or allergic conjunctivitis.
  • Avoid Sharing Medications: Sharing can spread resistant bacteria between individuals.

Importance for Healthcare Professionals

Healthcare providers play a crucial role in minimizing antibiotic resistance by:

  • Providing Clear Instructions: Ensure patients understand how and when to use the medication correctly.
  • Limiting Over-Prescription: Prescribe erythromycin only when a bacterial infection is confirmed or strongly suspected.
  • Educating Patients: Raise awareness about the risks of resistance and the importance of adherence to prescribed treatments.

Frequently Asked Questions (FAQ)

Here are answers to some frequently asked questions:

Can erythromycin ophthalmic ointment be used for viral infections?

No, erythromycin ophthalmic ointment is only effective against bacterial infections. It does not work for viral eye infections, such as those caused by adenoviruses (commonly responsible for viral conjunctivitis).Β 

Using antibiotics for viral infections can lead to unnecessary side effects and contribute to antibiotic resistance.

What if symptoms don't improve after a few days?

If your symptoms do not improve within 2–3 days of using erythromycin as prescribed, or if they worsen, consult your healthcare provider.Β 

Persistent symptoms may indicate a resistant bacterial strain, an incorrect diagnosis (e.g., viral or allergic conjunctivitis), or a different underlying eye condition requiring further evaluation.

Is erythromycin ophthalmic ointment safe for children or pregnant women?

Yes, erythromycin is considered safe for both children and pregnant women when used as directed:

  • Children: It is commonly prescribed for pediatric eye infections and is especially used to prevent newborn infections.
  • Pregnant Women: Classified as a Category B medication by the FDA, erythromycin is generally safe during pregnancy as it has not shown harmful effects in studies. However, always consult a healthcare provider before use.

[signup]

Key Takeaways

  • Erythromycin ophthalmic ointment is an antibiotic that treats bacterial eye infections such as conjunctivitis and blepharitis and prevents neonatal infections like ophthalmia neonatorum.
  • It works by stopping bacterial growth, is gentle on sensitive eyes, and is safe for children, newborns, and individuals with allergies to other antibiotics.
  • Correct application involves placing a thin strip of ointment in the lower eyelid without contaminating the tube tip, and blurred vision is a common but temporary side effect.
  • To minimize antibiotic resistance, patients should complete the entire course, use the medication only for bacterial infections, and avoid sharing the ointment.
  • Consult a healthcare provider if symptoms worsen or persist after a few days, which may indicate resistance or a misdiagnosed condition.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Aramă, V. (2020). Topical antibiotic therapy in eye infections - myths and certainties in the era of bacterial resistance to antibiotics. Romanian Journal of Ophthalmology, 64(3), 245. https://pmc.ncbi.nlm.nih.gov/articles/PMC7739555/

Bertino. (2009). Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics. Clinical Ophthalmology, 507. https://doi.org/10.2147/opth.s5778

Brown, T. A. (2002). Genome Replication. In www.ncbi.nlm.nih.gov. Wiley-Liss. https://www.ncbi.nlm.nih.gov/books/NBK21113/

CDC. (2019, September 3). Adenovirus | About | CDC. Www.cdc.gov. https://www.cdc.gov/adenovirus/about/index.html

CDC. (2024, April 24). Types of Bacterial Conjunctivitis. Conjunctivitis (Pink Eye). https://www.cdc.gov/conjunctivitis/hcp/clinical-overview/bacterial-types.html

Cleveland Clinic. (n.d.). Erythromycin eye ointment. Cleveland Clinic. https://my.clevelandclinic.org/health/drugs/19501-erythromycin-eye-ointment

Cloyd, J. (2023, April 20). Antibiotics 101: What You Need To Know. Rupa Health. https://www.rupahealth.com/post/antibiotics-101-what-you-need-to-know

Epling, J. (2012). Bacterial conjunctivitis. BMJ Clinical Evidence, 2012, 0704. https://pmc.ncbi.nlm.nih.gov/articles/PMC3635545/

Erythromycin Immediate-Release Tablets: Uses & Side Effects. (n.d.). Cleveland Clinic. https://my.clevelandclinic.org/health/drugs/18220-erythromycin-immediate-release-tablets

Erythromycin Ophthalmic Ointment USP, 0.5% (Sterile). (n.d.). Dailymed.nlm.nih.gov. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=9d0c2d52-0a9d-4656-88dd-adffb37f2501

Farzam, K., Nessel, T. A., & Quick, J. (2022). Erythromycin. PubMed; StatPearls Publishing. https://pubmed.ncbi.nlm.nih.gov/30335282/

Gaynes, R. (2017). The Discovery of Penicillinβ€”New Insights After More Than 75 Years of Clinical Use. Emerging Infectious Diseases, 23(5), 849–853. https://doi.org/10.3201/eid2305.161556

Karbassi, E., Amiri-Ardekani, E., Farsinezhad, A., Shahesmaeili, A., Abhari, Y., Ziaesistani, M., Pouryazdanpanah, N., Derakhshani, A., Jamshidi, F., & Tajadini, H. (2022). The Efficacy of Kohl (Surma) and Erythromycin in Treatment of Blepharitis: An Open-Label Clinical Trial. Evidence-Based Complementary and Alternative Medicine, 2022, 1–6. https://doi.org/10.1155/2022/6235857

Kernt, K., Martinez, M. A., Bertin, D., Stroman, D., Cupp, G., MartΓ­nez, C., Tirado, M., Guasch, J., & International Tobrex2x Group (Eu). (2005). A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis. European Journal of Ophthalmology, 15(5), 541–549. https://pubmed.ncbi.nlm.nih.gov/16167284/

Kresge, K. (2022, July 15). 7 Ways To Relieve Your Seasonal Allergies Backed By Science. Rupa Health. https://www.rupahealth.com/post/7-proven-ways-to-get-seasonal-allergy-relief

Matejcek, A., & Goldman, R. D. (2013). Treatment and prevention of ophthalmia neonatorum. Canadian Family Physician, 59(11), 1187. https://pmc.ncbi.nlm.nih.gov/articles/PMC3828094/

Matinzadeh, Z. K., Beiragdar, F., Kavemanesh, Z., Abolgasemi, H., & Amirsalari, S. (2007). Efficacy of topical ophthalmic prophylaxis in prevention of ophthalmia neonatorum. Tropical Doctor, 37(1), 47–49. https://doi.org/10.1258/004947507779951880

McElhiney, L. F. (2010). Developing an erythromycin ophthalmic ointment: putting the puzzle pieces together. International Journal of Pharmaceutical Compounding, 14(4), 270–274. https://pubmed.ncbi.nlm.nih.gov/23965533/

Medline Plus. (2019, December). Erythromycin Ophthalmic: MedlinePlus Drug Information. Medlineplus.gov. https://medlineplus.gov/druginfo/meds/a613018.html

MedlinePlus. (2018). Anaphylaxis: MedlinePlus Medical Encyclopedia. Medlineplus.gov. https://medlineplus.gov/ency/article/000844.htm

National Eye Institute. (2020, August 31). Blepharitis | National Eye Institute. Www.nei.nih.gov. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/blepharitis

National Foundation for Infectious Diseases. (2019, August 29). Antibiotic Resistance. National Foundation for Infectious Diseases. https://www.nfid.org/antibiotic-resistance/

Olsson, A., Allander, L., Shams, A., Al-Farsi, H., LagerbΓ€ck, P., & TΓ€ngdΓ©n, T. (2023). Activity of polymyxin B combinations against genetically well-characterised Klebsiella pneumoniae producing NDM-1 and OXA-48-like carbapenemases. International Journal of Antimicrobial Agents, 62(5), 106967. https://doi.org/10.1016/j.ijantimicag.2023.106967

Ovung, A., & Bhattacharyya, J. (2021). Sulfonamide drugs: structure, Antibacterial property, toxicity, and Biophysical Interactions. Biophysical Reviews, 13(2), 259–272. https://doi.org/10.1007/s12551-021-00795-9

Patel, P. H., & Hashmi, M. F. (2023, May 16). Macrolides. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK551495/

Platon, V.-M., Dragoi, B., & Marin, L. (2022). Erythromycin Formulationsβ€”A Journey to Advanced Drug Delivery. Pharmaceutics, 14(10), 2180. https://doi.org/10.3390/pharmaceutics14102180

Rodrigues, R., Marques, L., Vieira-Baptista, P., Sousa, C., & Vale, N. (2022). Therapeutic Options for Chlamydia trachomatis Infection: Present and Future. Antibiotics, 11(11), 1634. https://doi.org/10.3390/antibiotics11111634

RomΓΈren, M., Lindbaek, M., & Nordeng, H. (2012). Pregnancy outcome after gestational exposure to erythromycin - a population-based register study from Norway. British Journal of Clinical Pharmacology, 74(6), 1053–1062. https://doi.org/10.1111/j.1365-2125.2012.04286.x

Solensky, R. (2023, January 11). Patient education: Allergy to penicillin and related antibiotics (Beyond the Basics). Www.uptodate.com. https://www.uptodate.com/contents/allergy-to-penicillin-and-related-antibiotics-beyond-the-basics/print

Springer, C., & Salen, P. (2023, April 17). Gonorrhea. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK558903/

Teweldemedhin, M., Gebreyesus, H., Atsbaha, A. H., Asgedom, S. W., & Saravanan, M. (2017). Bacterial profile of ocular infections: a systematic review. BMC Ophthalmology, 17(1). https://doi.org/10.1186/s12886-017-0612-2

Ventola, C. L. (2015). The Antibiotic Resistance Crisis: Part 1: Causes and Threats. Pharmacy and Therapeutics, 40(4), 277. https://pmc.ncbi.nlm.nih.gov/articles/PMC4378521/

Watanabe, R. (2010). Fluoroquinolone antibacterial eye drops: effects on normal human corneal epithelium, stroma, and endothelium. Clinical Ophthalmology, 1181. https://doi.org/10.2147/opth.s13672

Yoshimura, H. (2023, September 5). An Integrative Approach to Recurring Stye Infections: Testing, Dietary Considerations, and Helpful Supplements. Rupa Health. https://www.rupahealth.com/post/integrative-approach-to-recurring-stye-infections

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless β€” and best of all, it's free for practitioners.

Latest Articles

View more on Medication Fact Sheets
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey practitioners! πŸ‘‹ Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.

Hey practitioners! πŸ‘‹ Join Dr. Terry Wahls for a 3-week bootcamp on integrating functional medicine into conventional practice, focusing on complex cases like Multiple Sclerosis. Learn to analyze labs through a functional lens, perform nutrition-focused physical exams, and develop personalized care strategies. Register Here.